Publication | Closed Access
Ombitasvir/Paritaprevir/R, Dasabuvir, and Sofosbuvir Treatment of Patients with HCV Genotype-Infection who Failed a Prior Course of DAA Therapy: The Quartz-I Study
27
Citations
0
References
2016
Year
Viral PersistenceViral HepatitisHcv Genotype-infectionAntiviral TherapyHepatitisVirologyDaa TherapyQuartz-i StudyInfection ControlAntiviral DrugChronic Viral InfectionMedicineEpidemiology
No additional data available for this publication yet. Check back later!